reference/34044302

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34044302

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	695
issn	1432-0843 0344-5704
issueIdentifier	5
pageRange	683-695
publicationName	Cancer Chemotherapy and Pharmacology
startingPage	683
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_da189140144769ac5481d92da3f44d53 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9a89ca22a8c18939b3f7c1e01dba8086 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_11d01e1a7391e64859e5955749ec51c5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cabe87d97f122d4519c6b14d45d1248c
bibliographicCitation	Xu J, Gao Y, Luan X, Li K, Wang J, Dai Y, Kang M, Lu C, Zhang M, Lu CX, Kang Y, Xu C. An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer. Cancer Chemotherapy and Pharmacology. 2022 Apr 13;89(5):683–95. doi: 10.1007/s00280-022-04403-9.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d89bb5ef471bcc6e4d1cad731fecacb0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1197-4727 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ed4be5608a235c2d3e9ed9fd460f64a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_459a407e80e92926051c268b6f70c217 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee621a5086ab77e4af5c4046dfdb7361 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e46fc8ef9407a9539067131af46288db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc32e9366482d266550a12165943b555 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfa5adb5d6eefc3cc7e9f6f1319265ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c57359a4755c5c0c8591bea44f81c04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c86668c4e44ea6f93bc715699b6f5a8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b97c912442035ecbdbfc1fceac1cf8d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfe407a3bad3382695237654962f09dc
date	2022-04-13^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s00280-022-04403-9 https://pubmed.ncbi.nlm.nih.gov/PMC9054880 https://pubmed.ncbi.nlm.nih.gov/35419627
isPartOf	https://portal.issn.org/resource/ISSN/1432-0843 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664 https://portal.issn.org/resource/ISSN/0344-5704
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer
discusses	http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M000649677 http://id.nlm.nih.gov/mesh/M0016766 http://id.nlm.nih.gov/mesh/M000601132 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M000613201 http://id.nlm.nih.gov/mesh/M0150739
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D010051Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051057Q000378 http://id.nlm.nih.gov/mesh/D004357 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D000971Q000494 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000077216Q000188 http://id.nlm.nih.gov/mesh/D000071137 http://id.nlm.nih.gov/mesh/D000081082 http://id.nlm.nih.gov/mesh/D010793Q000494 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D010793Q000627 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D000067856Q000627 http://id.nlm.nih.gov/mesh/D019869 http://id.nlm.nih.gov/mesh/D000067856Q000494 http://id.nlm.nih.gov/mesh/D023041
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_effabf75f87a02358f0a8868edaf2c9f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_467b750f9a6073f1098d1aa6270e135d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5f8f19d61252fdce5cae1f415ad035b2

Showing number of triples: 1 to 73 of 73.